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Summary 
Twenty-three  patients  with  a  major  depressive  disorder  were  deprived  of  a  night’s  sleep  twice  weekly, 
one  week  staying  up  in  the  dimly  lit  living  room  of  the  ward  (<  60  lux),  and  one  week  in  a  brightly  lit 
room  (>  2000  lux).  Immediate,  but  transient  beneficial  effects  of  sleep  deprivation  were  observed 
primarily  in  eight  patients  (the  ‘responders’).  The  immediate  effects  did  not  differ  greatly  for  the  two 
conditions,  indicating  that  exposure  to  light  at  night  is  an  implausible  explanation  for  the  antidepressant 
effects  of  total  sleep  deprivation.  There  was  some  evidence  that  the  bright  light  condition  led  to  a  more 
prolonged  improvement  of  the  responders. 
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Introduction 
One  night  of  total  sleep  deprivation  (TSD)  is 
known  to  lead  to  improvement  in  many  depressed 
patients  (for  a  review,  see  Gillin,  1983).  However, 
the  antidepressant  effect  is  nearly  always  tran- 
sient,  the  typical  pattern  being  a  relapse  after 
subsequent  sleep.  Ways  are  sought,  therefore,  to 
prevent  this  relapse,  for  example  by  using  special 
time  schedules  of  sleep  deprivation  (total  or  par- 
tial)  and/or  by  combining  sleep  deprivation  with 
Address  for  correspondence:  W.  van  den  Burg,  Department 
of  Neuropsychology,  Neurological  Clinic,  University  Hospital, 
Oostersingel  59,  9713  EZ  Groningen,  The  Netherlands. 
other  treatment.  Some  of  these  attempts  may  de- 
velop  into  practical  therapy,  but  it  is  still  much 
too  early  to  speak  of  a  major  breakthrough.  Paral- 
lel  to  these  investigations,  research  is  being  de- 
voted  to  the  clarification  of  the  still  unknown 
mechanism  of  the  antidepressant  response.  Van 
den  Hoofdakker  and  Beersma  (1988)  and  Wehr  et 
al.  (1988)  review  a large  number  of  recent  studies. 
Another  successful  intervention,  also  of  a  bio- 
logical  but  non-pharmacological  nature,  consists 
of  the  administration  of  artificial  bright  light.  The 
efficacy  of  this  treatment  has  been  demonstrated 
particularly  with  regard  to  seasonal  affective  dis- 
orders  (Yerevanian  et  al.,  1986;  Terman  et  al., 
1989)  but  reports  have  also  appeared  indicating  a 
beneficial  effect  in  more  classical  types  of  depres- 
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sion  (Fleischhauer  et  al.,  1988;  Kripke,  1989). 
Regarding  the  effectiveness  in  treating  seasonal 
affective  disorders,  Terman  et  al.  (1989)  reviewed 
the  studies  to  date  and  summarized  some  of  the 
findings  as  follows:  ‘In  most  studies,  patients  were 
exposed  to  light  for  2 to  6 hours  per  day,  although 
some  patients  have  apparently  benefited  from 
durations  of  30  minutes  to  1  hour.  The  antide- 
pressant  response  usually  occurs  within  3  to  4 
days  of  treatment,  with  a  similar  time  course  for 
relapse  during  withdrawal.  A  few  studies,  how- 
ever,  have  suggested  protracted  post-treatment 
benefit  of  up  to  several  weeks’  (p.  2).  In  their 
meta-analysis,  Terman  et  al.  (1989)  established 
that,  in  the  treatment  of  disorders  of  low  severity, 
light  therapy  was  most  effective  when  applied  in 
the  early  morning.  No  time  dependence  of  the 
antidepressant  response  was,  however,  found  in 
moderate  to  severe  cases.  Although  it  is  unclear 
how  long  the  remission  would  typically  be  sus- 
tained  in  this  group  after  discontinuation  of  light 
therapy,  the  data  in  general  suggest  that  it  would 
be  longer  than  the  usual  single-day  response  pro- 
duced  by  TSD. 
In  the  present  investigation,  we  compared  the 
efficacy  of  TSD  in  dimly  lit  and  brightly  lit  sur- 
roundings.  Since  both  TSD  and  bright  light  ap- 
pear  to  have  antidepressant  potential,  the  simulta- 
neous  application  of  these  two  modes  of  treatment 
may  lead  to  more  substantial  effects.  We  at- 
tempted  to  obtain  a  more  lasting  antidepressant 
response  by  applying  TSD  twice,  using  the  sched- 
ule:  sleep  -  TSD  -  sleep  -  TSD  ~  sleep.  Our 
reasoning  was  that  the  usual  relapse  subsequent  to 
the  first  night  of  sleep  following  TSD  might  be 
(partially)  offset  by  a  more  protracted  response 
due  to  the  addition  of  bright  light.  A  second  TSD 
might  then  give  a  further  ‘push’  towards  recovery. 
The  subjects  were  seriously  depressed  patients  with 
the  symptoms  of  a  non-seasonal,  major  depressive 
disorder. 
A  second  rationale  for  conducting  this  study 
was  based  on  the  idea  that  the  exposure  to  light 
that  normally  accompanies  TSD  could  be  the  cru- 
cial  mediating  factor  in  producing  the  antide- 
pressant  response.  If  this  is  the  case,  one  might 
expect  the  combination  of  TSD  and  exposure  to 
very  bright  light  to  have  an  antidepressant  effect 
which  occurs  earlier  and  more  frequently  and 
which  is  greater  and  possibly  less  transient.  Kripke 
(1981)  put  forward  the  hypothesis  that,  in  particu- 
lar,  exposure  to  light  in  the  very  early  morning  is 
the  effective  stimulus.  In  agreement  with  this  sup- 
position,  Kripke  et  al.  (1983a,b)  reported  that 
waking  up  (non-seasonally)  depressed  patients  at 
5  a.m.  and  administering  very  bright  light  for  1  h 
had  a  greater  antidepressant  effect  than  dim  light 
exposure  at  the  same  time  or  early  in  the  night.  An 
alternative  explanation  of  these  results,  however, 
is  that  the  light  per  se is  not  the  crucial  factor,  but 
that  phase  shifts  of  circadian  rhythms  caused  by 
the  light  exposure  are  responsible  for  these  effects 
(Lewy  et  al.,  1985).  It  has  recently  been  shown 
that  bright  light  exposure  in  the  early  morning 
does  indeed  cause  a  phase  shift  of  the  human 
circadian  pacemaker  (Dijk  et  al.,  1988).  Bright 
light  exposure  in  the  evening,  on  the  other  hand, 
also  causes  a  phase  shift,  but  in  the  opposite 
direction  (Czeisler  et  al.,  1986).  It  can  therefore  be 
expected  that  all-night  exposure  to  bright  light  will 
induce  both  types  of  phase  shift  within  one  night, 
leading  probably  to  virtually  no  change.  Hence, 
the  present  investigation  will  allow  a  less  con- 
founded  study  of  the  role  of  light  in  producing  the 
antidepressant  response  to  TSD. 
Our  study  can  be  regarded  as  a  sequel  to  a 
small-scale  investigation  by  Wehr  and  his  col- 
leagues  (1985).  which  also  addressed  Kripke’s  hy- 
pothesis.  These  investigators  applied  TSD  once  in 
nearly  complete  darkness  and  once  in  very  bright 
light,  with  an  interval  of  approximately  a  week. 
The  subjects  were  two  non-seasonal  and  three 
seasonal  depressives.  The  results  partly  confirmed 
that  the  addition  of  bright  light  affects  the  antide- 
pressive  response  to  TSD  in  the  direction  pre- 
sumed.  During  the  TSD  night,  the  patients  im- 
proved  more,  relative  to  pretreatment  levels,  when 
bright  light  was  administered.  This  suggests  that 
exposure  to  bright  light  triggers  an  earlier  re- 
sponse.  Comparing  the  state  of  the  patients  on  the 
days  before  and  after  TSD,  however,  no  ad- 
ditional  beneficial  effect  of  the  bright  light  condi- 
tion  could  be  assessed  (perhaps  due  to  the  small 
sample  size).  Particularly  interesting  was  the  ob- 
servation  that  for  three  patients  the  ‘improvement 
persisted  for  nearly  one  week  after  the  bright  light 
sleep  deprivation  but  for  only  a day  or  so  after  the 
dim  light  sleep  deprivation’.  As  the  authors  noted, 111 
however,  these  were  anecdotal  observations  not 
supported  by  objective  ratings,  and  the  three  pa- 
tients  concerned  were  those  diagnosed  as  seasonal 
depressives.  All  patients  eventually  relapsed. 
The  patients  in  Wehr  et  al.‘s  study  were  all 
drug-free  and  additional  medication  might  con- 
ceivably  have  prevented  the  eventual  relapse.  For 
this  reason,  and  also  because  of  more  general 
considerations  concerning  practical  relevance, 
feasibility  and  ethics,  the  patients  in  our  study 
received  appropriate  medication.  This  medication, 
however,  was  kept  constant  during  the  trial. 
In  summary,  four  questions  were  addressed  in 
the  present  investigation. 
-  Does  the  combination  of  bright  light  and  TSD 
(‘bright  light  TSD’)  lead  to  an  antidepressive 
response  more  often  than  TSD  without  this 
addition  (‘dim  light  TSD’)? 
-  Comparing  the  state  of  the  patients  on  the  days 
before  and  after  TSD,  are  the  immediate  re- 
sponses  to  bright  light  TSD  greater  than  those 
to  dim  light  TSD? 
-  Does  any  antidepressant  effect  appear  earlier 
with  bright  light  TSD  than  with  dim  light  TSD? 
_  Does  the  antidepressant  response  following 
bright  light  TSD  last  longer  than  that  following 
dim  light  TSD? 
The  patients  concerned  in  the  study  were  poten- 
tially  on  pharmacological  treatment  for  depres- 
sion. 
Patients  and  methods 
The  investigation  was  carried  out  in  the  Bio- 
logical  Psychiatry  Unit  of  the  University  of 
Groningen.  The  Netherlands.  Consecutively  ad- 
mitted  patients  were  considered  for  participation 
if  their  self-ratings  on  the  Beck  Depression  Inven- 
tory  (Beck  et  al.,  1961),  as  assessed  on  the  first 
Monday  morning  of  the  (possible)  trial,  exceeded 
16;  this  was  regarded  as  indicative  of  a  moderate 
to  severe  depression.  Such  patients  were  given  an 
extensive  interview  in  order  to  make  a  precise 
diagnosis  and  to  assess  the  patient’s  status  with 
regard  to  the  Hamilton  Depression  Rating  Scale 
(Hamilton,  1967).  If  a  serious  depression 
dominated  the  clinical  picture,  the  patients  were 
asked  to  participate  after  our  procedures  had  been 
fully  explained.  Written  consent  was  obtained  from 
all  subjects.  Twenty-eight  patients  entered  the 
study,  but  two  left  half-way  through,  having  de- 
cided  that  they  did  not  want  to  participate  any 
longer.  The  data  of  three  further  patients  were 
excluded  from  the  analysis.  One  patient  sponta- 
neously  remitted  before  the  first  TSD  and  re- 
mained  stable  during  the  rest  of  the  trial.  The 
self-ratings  of  the  second  patient  were  clearly  un- 
reliable.  The  third  patient  suddenly  worsened  dur- 
ing  the  study  to  such  a  degree  that  a  large  ad- 
ditional  dose  of  neuroleptics  was  required.  The 
medication  of  the  remaining  23  patients,  upon 
whose  data  our  analysis  is  based,  was  left  un- 
changed  during  the  study,  except  that  occasionally 
a  benzodiazepine  in  low  dosage  was  given  upon 
request  (but  not  during  the  TSD  nights  or  on  the 
days  immediately  following).  Five  patients  were 
medication-free.  The  medication  consisted  mainly 
of  the  neuroleptics  triflupromazine  and  haloperi- 
do1  (seven  patients),  the  tricyclic  antidepressants 
clomipramine  and  amitriptyline  (11  patients),  and 
lithium  (two  patients).  Five  patients  received  only 
neuroleptics.  These  were  psychotic  depressive  pa- 
tients  who  entered  the  study  shortly  after  admis- 
sion  to  our  ward.  Before  admission  they  had  al- 
ready  been  treated  with  neuroleptics  for  some 
time,  and  we  were  reluctant  to  introduce  (ad- 
ditional)  antidepressant  medication  in  these  cases 
in  order  to  avoid  contamination  of  the  effects  of 
major  pharmacological  changes  and  of  TSD.  Ta- 
ble  1, to  be  discussed  further  in  the  Results  section 
and  the  Discussion,  contains  more  detailed  infor- 
mation  on  the  medication.  All  but  two  patients 
met  the  DSM-III  criteria  for  major  depression 
(296.2  and  296.3).  The  classifications  of  the  two 
remaining  patients  were  atypical  bipolar  disorder, 
depressive  phase  (296.7)  and  atypical  depression 
(296.8).  The  patients  did  not  display  the  typical 
symptoms  of  a  seasonal  affective  disorder 
(Rosenthal  et  al.,  1984)  nor  did  they  mention  any 
seasonality  of  their  depression.  Close  or  sys- 
tematic  inquiries  after  a  possible  seasonal  depen- 
dence  were  not  made,  however.  The  group  con- 
sisted  of  11  women  and  12  men  with  a  mean  age 
of  47.2  years  (SD  =  13.6;  range  24-68  years).  The 
mean  Hamilton  score  was  23.9,  with  a  range  of 
15-38  (SD  =  6.4).  For  the  computation  of  the 
Hamilton  score,  only  the  first  17  items  in  the  scale 
were  considered  (Hamilton,  1986). 112 
The  trial  lasted  2 weeks  and  always  began  on  a 
Monday.  The  patients  were  deprived  of  sleep  dur- 
ing  the  nights  of  Tuesday  to  Wednesday  and  of 
Thursday  to  Friday.  In  one  week  they  stayed  up  in 
the  dimly  lit  living  room  of  the  ward  (<  60  lux), 
and  in  the  other  week  they  stayed  in  a  separate, 
brightly  lit  room,  from  11 p.m.  to  7 a.m.  The  order 
of  the  two  weeks  was  randomly  arranged  in  this 
cross-over  design.  During  sleep  deprivation  under 
bright  light  conditions,  patients  sat  at  a  table  in 
front  of  a  plexiglass  screen,  behind  which  eight 
white  fluorescent  tubes  (Vita  light  tubes)  were 
vertically  placed.  The  screen,  positioned  at  a maxi- 
mum  distance  of  1  m  from  the  patient,  served  to 
spread  the  light  and  reduce  UV  content.  The 
patients  read,  did  some  manual  work  or  did  noth- 
ing  at  all,  whatever  they  pleased.  They  were  asked 
to  look  at  the  screen  at  least  once  every  minute.  At 
eye  level,  the  light  intensity  was  >  2000  lux.  A 
member  of  the  nursing  staff  was  always  present. 
During  all  TSD  nights  and  on  the  subsequent 
days,  the  patients  were  closely  monitored  in  order 
to  check  tendencies  to  take  a  nap.  Of  the  23 
patients,  11  received  bright  light  TSD  and  12 
received  dim  light  TSD  during  the  first  week. 
On  the  two  Monday  mornings  of  the  trial  and 
on  the  Monday  morning  immediately  following  it, 
the  patients  rated  their  condition  using  the  Beck 
Depression  Inventory.  From  Tuesday  to  Saturday, 
daily  at  9 a.m.,  5 p.m.  and  10 p.m.,  and  during  the 
TSD  nights  at  1 a.m.  and  5 a.m.,  the  patients  rated 
themselves  using  von  Zerssen’s  ‘Adjective  Mood 
Scale’  (von  Zerssen,  1976,  1986).  The  ‘Adjective 
Mood  Scale’  is  a  28-item  scale  for  self-rated  de- 
pression  with  scores  ranging  from  0  (not  de- 
pressed)  to  56,  and  is  particularly  suited  for  fre- 
quent  use  at  short  intervals.  A  specially  assigned 
research  assistant,  together  with  the  nursing  staff, 
ensured  that  the  forms  were  completed  conscien- 
tiously  and  on  time.  The  Dutch  versions  of  both 
the  Beck  inventory  (Bouman  et  al.,  1985)  and  the 
von  Zerssen  scale  (Elsenga,  1988)  have  been  shown 
to  be  psychometrically  reliable. 
Because  the  research  design  had  a  ‘cross-over’ 
structure,  within-subject  differences  could  be  used 
for  assessing  treatment  effects.  The  statistical  tests 
based  on  these  differences,  however,  were  always 
preceded  by  preliminary  checks  for  possible  inter- 
action  effects  between  period  and  treatment,  the 
presence  of  which  might  make  the  results  difficult 
to  interpret.  The  procedures  described  by  Hills 
and  Armitage  (1979)  were  followed.  No  interac- 
tion  effects  were  clearly  demonstrable.  Unless 
otherwise  noted,  the  Mann-Whitney  test  was  used 
for  statistical  analysis. 
Results 
Fig.  1  shows  the  mean  self-ratings  on  the  von 
Zerssen  scale  during  the  two  treatments.  Under 
both  conditions  the  typical  effect  of  TSD  on  de- 
pression  is  apparent,  i.e.,  improvement  on  the  day 
immediately  following  TSD  and  relapse  after  sub- 
sequent  sleep.  When  a  comparison  is  made  across 
conditions  between  the  overall  mean  scores  on  the 
days  after  TSD  (Wednesday  and  Friday)  and  the 
mean  scores  on  the  other  days  (Tuesday,  Thursday 
and  Saturday),  the  difference  is  significant 
(Wilcoxon  signed  ranks  test,  P K 0.025).  However, 
inspection  of  the  data  showed  that  this  difference 
was  primarily  produced  by  a  minority  of  the  pa- 
tients  who  clearly  responded  to TSD.  Using  criteria 
corresponding  to  those  previously  applied  in  our 
clinic  (Elsenga  and  van  den  Hoofdakker,  1987) 
‘responders’  were  defined  as  patients  who,  for  at 
least  two  of  the  four  TSDs,  had  a  mean  von 
Zerssen  score  on  the  day  after  TSD  that  was  6  or 
more  points  lower  than  the  mean  score  on  the  day 
before.  Using  this  definition,  eight  responders  were 
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Fig.  1. Mean  response  to  sleep  deprivation,  total  group  (n  =  23). 
- - -  - -  Sleep  deprivation  in  dim  light,  ~  sleep  depriva- 
tion  in  bright  light.  The  van  Zerssen  ‘Adjective  Mood  Scale’ 
was  used  for  the  self-ratings. -T”os~ar-Wod”esday-iO”.oda~~frlday--hSat”r~al- 
Fig.  2.  Mean  response  to  sleep  deprivation,  responders  (n  =  8). 
______  Sleep  deprivation  in  dim  light,  -  sleep  depriva- 
tion  in  bright  light.  The  von  Zerssen  ‘Adjective  Mood  Scale’ 
was  used  for  the  self-ratings. 
identified.  The  data  for  the  responders  are  shown 
in  Fig.  2.  There  were  no  significant  differences 
between  responders  and  non-responders  with  re- 
spect  to  age,  gender  or  pretreatment  depressive- 
ness  (self-ratings  on  the  Beck  scale  on  the  first 
Monday  of  the  trial  and  mean  self-ratings  on  the 
von Zerssen  scale  on  the first  Tuesday  of  the  trial). 
However,  responders  and  non-responders  differed 
conspicuously  with  regard  to  the  medication  re- 
ceived  (Table  1).  The  curious  distribution  shown 
in  Table  1 will  be  further  commented  upon  in  the 
Discussion.  Regarding  the  question  whether  the 
response  to  bright  light  TSD  is  different  from  the 
response  to  dim  light  TSD,  however,  it  is  relevant 
to  note  here  that  the  responders  who  received  the 
light  treatments  in  the  order  bright-dim  did  not 
differ  from  the  responders  who  received  the  light 
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treatments  in  the  order  dim-bright:  the  first  sub- 
group  consisted  of  three  patients  of whom  one  was 
medication-free,  and  the  second  subgroup  con- 
sisted  of  five  patients  of  whom  two  were  medica- 
tion-free.  Results  pertaining  to  the  four  questions 
posed  at  the  end  of  the  Introduction  will  be  pre- 
sented  below  separately  for  the  total  group  of  23 
patients  and  for  the  subgroup  of  eight  responders. 
Within  the  subgroup  of  non-responders  (n  =  15) 
none  of  the  analyses  to be  discussed  yielded  statis- 
tically  significant  results. 
Using  the criterion  of  a mean  improvement  of 6 
points  on  the  von  Zerssen  scale  for  assessing  a 
response  or  non-response  to  TSD,  the  frequencies 
of  response  under  the  two TSD  conditions  were  as 
follows.  Of  the  total  group  of  23  subjects,  nine 
responded  to  the  first  bright  light  TSD  and  five  to 
the  second.  These  results  were  six  and  seven,  re- 
spectively,  following  the  dim  light  TSD.  In  the 
subgroup  of  eight  responders,  all  eight  responded 
to  the  first  bright  light  TSD  and  five  responded  to 
the  second,  while  the  corresponding  results  under 
dim  light  conditions  were  six  and  six.  No  formal 
statistical  test  was  deemed  necessary  to  determine 
the  non-significance  of  these  differences.  Other 
criteria,  applied  to  maximal  rather  than  mean 
differences  between  pre-  and  post-TSD  scores, 
also  failed  to  suggest  a  differential  effect  between 
the  two  conditions. 
In  comparing  the  mean  magnitudes  of  the  im- 
mediate  responses,  we  considered  the  differences 
between  the  mean  self-ratings  on  the  days  before 
and  after  the  TSD  nights,  as  well  as  the  dif- 
ferences  between  the  mean  scores  on  the  days 
before  TSD  and  the  minimal  (‘least  depressive’) 
TABLE  7 
MEDICATION  OF  RESPONDERS  AND  NON-RESPONDERS:  FREQUENCIES 
AD  AD 
>lOd.  <lOd. 
Neuroleptics 
only 
Lithium 
only 
Medication- 
free 
Total 
Responders  5 (1)  3  8 
Non-responders  3 (2)  3 (1)  5  2  2  15 
Total  8  3  5  2  5  23 
AD  >  10 d.,  tricyclic  antidepressants  used  for  more  than  10  days  before  the  trial  started;  AD  i  10  d.,  tricyclic  antidepressants  used  for 
less  than  10  days  before  the  trial  started.  The  frequencies  in  parentheses  indicate  the  numbers  of  patients  who  received  neuroleptics  in 
addition  to  the  antidepressant  medication. 114 
TABLE  2 
SELF-RATINGS  ON  THE  BECK  DEPRESSION  INVEN- 
TORY:  MEANS  (SD) 
Monday  1  Monday  2  Monday  3 
Total group (n = 23) 
BD  33.2  -B-  29.0  -D-  21.9 
(n  =  11)  (10.5)  (12.7)  (11.0) 
DB  28.4  -D-  27.8  -B-  25.5 
(n  =12)  (9.5)  (10.5)  (11.6) 
Responders (n = 8) 
BD  29.7  -B-  16.0  -D-  18.0 
(n=3)  (7.8)  (5.2)  (3.9) 
DB  29.2  -D-  32.6  -B-  30.8 
(n  =  5)  (9.0)  (14.0)  (16.2) 
-B-,  week  of  bright  light  TSD;  -D-,  week  of  dim  light  TSD;  BD 
and  DB  indicate  the  subgroups  who  received  the  TSD  treat- 
ments  in  the  order  bright-dim  and  dim-bright,  respectively. 
(P  <  0.05).  However,  this  earlier  response  could 
not  be  established  during  the  second  TSD.  Using 
scores  averaged  across  the  two  TSDs,  the  compari- 
son  did  not  yield  treatment  effects  at  a  statistically 
significant  level. 
self-ratings  on  the  days  following  TSD.  No  com- 
parison  yielded  significant  results  or  trends  worth 
mentioning.  This  was  also  true  when  the  first  and 
second  TSD  within  each  condition  were  consid- 
ered  separately. 
In  order  to  evaluate  whether  bright  light  TSD 
had  a  more  lasting  effect  than  dim  light  TSD,  the 
Monday  to  Monday  differences  on  the  Beck  De- 
pression  Inventory  were  considered,  as  were  the 
Tuesday  to  Saturday  and  Tuesday  to  Tuesday 
differences  on  the  von  Zerssen  scale.  Tables  2 and 
3 show  the  data,  separately  for  the  total  group  and 
for  the  group  of  responders,  and  separately  for  the 
subgroups  who  received  the  treatments  in  the  order 
bright-dim  (BD)  and  for  the  subgroups  who  re- 
ceived  the  treatments  in  the  order  dim-bright 
(DB).  The  two  tables  do  indeed  show  a  trend  in 
favor  of  bright  light  TSD.  In  the  group  of  re- 
sponders,  significance  was  reached  for  the  Beck 
data  (at  P =  0.05)  but  (just)  not  for  the  von 
Zerssen  data.  For  the  total  group  these  trends 
were  not  significant.  Apparently,  the  more  lasting 
effect  of  bright  light  TSD  was  restricted  to  the 
subgroup  of  responders. 
To  assess  whether  bright  light  TSD  induces  an  Table  2  also  suggests  that,  within  the  subgroup 
earlier  antidepressant  response,  the  differences  be-  of  responders,  the  more  lasting  effect  of  bright 
tween  the  mean  self-ratings  on  the  days  before  light  TSD  was  further  restricted  primarily  to  the 
TSD  and  the  mean  self-ratings  during  TSD  (at  1  three  patients  who  received  bright  light  TSD  in 
and  5  a.m.)  were  considered.  For  both  the  total  the  first  week  of  the  experimental  period.  How- 
group  and  the  subgroup  of  responders,  more  im-  ever,  the  test  for  a  possible  period  x  treatment 
provement  was  observed  during  the  first  bright  interaction  effect  was  (only  just)  not  significant, 
light  TSD  than  during  the  first  dim  light  TSD  while  the  von  Zerssen  data  of  the  responders 
TABLE  3 
SELF-RATINGS  ON  THE  VON  ZERSSEN  SCALE:  MEANS  (SD) 
Tuesday  1  Saturday  1  Tuesday  2  Saturday  2 
Total group (n = 23) 
BD  45.4 
(n  =11)  (5.6) 
DB  40.9 
(n  =12)  (9.8) 
Responders (n = 8) 
BD  44.2 
(n=3)  (2.1) 
DB  48.2 
(n = 5)  (4.2) 
-B-  39.1 
(10.3) 
-D-  35.7 
(12.3) 
-B-  31.6 
(7.9) 
-D-  39.7 
(10.4) 
40.4 
(9.7) 
38.8 
(9.9) 
34.1 
(8.2) 
45.4 
(5.6) 
-D-  38.9 
(9.7) 
-B-  31.8 
(13.4) 
-D-  33.2 
(7.2) 
-B-  29.9 
(19.5) 
-B-,  week  of  bright  light  TSD;  -D-,  week  of  dim  light  TSD;  BD  and  DB  indicate  the  subgroups  who  received  the  TSD  treatments  in 
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(Table  3)  do  not  carry  the  suggestion  of  such  an 
interaction  effect.  All  in  all,  it  can  be  concluded 
that  the  data  of  the  responders  show  some  evi- 
dence  of  a  more  lasting  antidepressive  effect  after 
bright  light  TSD. 
Discussion 
The  findings  of  Wehr  et  al.  (1985)  were  all 
reproduced  in  the  present  study,  but  our  results 
clearly  call  for  some  amendments.  Comparing  the 
self-ratings  during  the  TSD  nights  with  those  of 
the  preceding  day,  we  found  evidence  that,  as  in 
the  study  by  Wehr  et  al.,  a  first  night  of  bright 
light  TSD  leads  to  a  faster  antidepressant  re- 
sponse  than  a  first  night  of  dim  light  TSD.  For  the 
second  TSD,  however,  this  difference  appeared  to 
vanish.  This  suggests  that  the  difference  for  the 
first  night  can  at  least  partly  be  attributed  to  the 
novelty  of  the  experience  of  treatment  with  bright 
light.  Also,  because  the  comparison  of  the  self-rat- 
ings  on  the  days  before  and  after  TSD  did  not 
yield  better  results  for  bright  light  TSD,  the  con- 
clusion  seems  warranted  that  the  immediate  anti- 
depressive  effect  caused  by  TSD  is  not  dependent 
on  the  amount  of  light  received  during  the  TSD 
night.  While,  as  Wehr  et  al.  note,  it  is  theoretically 
possible  that  a  minimal  supply  of  light  at  night  is 
necessary  for  the  antidepressant  response  to  take 
place,  perhaps  in  combination  with  the  light  expe- 
rienced  after  sunrise,  the  data  strongly  suggest 
that  other  mechanisms  to  explain  the  immediate 
response  to  TSD  must  be  sought.  Furthermore,  if 
the  time  of  sunrise  and  the  amount  of  light  experi- 
enced  thereafter  are  influential  factors,  one  would 
expect  comparatively  less  responsiveness  to  TSD 
during  the  dark  and  cloudy  Dutch  winters.  Elsenga 
and  van  den  Hoofdakker  (1987),  however,  have 
found  no  evidence  for  a  seasonal  influence. 
To  what  extent  the  medication  might  have  af- 
fected  the  immediate  response  to  TSD  is  difficult 
to  decide  within  the  confines  of  the  present  study. 
Table  1  shows  that  the  responders  either  were 
subjects  who  had  already  used  antidepressants  for 
more  than  10  days  when  entering  the  trial  or  were 
medication-free.  There  is  some  evidence  that 
clomipramine,  the  antidepressant  used  most  often 
in  the  present  study,  favorably  affects  the  im- 
mediate  response  to  repeated  sleep  deprivations 
(Elsenga  and  van  den  Hoofdakker,  1989).  The 
data  in  Table  1  do  not  contradict  this.  More 
remarkable,  however,  is  that  eight  of  the  15  non- 
responders  were  treated  with  neuroleptics.  against 
one  of  the  eight  responders  (x’(l)  =  3.65,  P  < 
0.03,  assuming  we  had  such  a  hypothesis  in  ad- 
vance).  If  this  is  not  merely  a  chance  result,  it 
might  mean  either  that  patients  eligible  for  treat- 
ment  with  neuroleptics  are  less  responsive  to  TSD 
or  that  neuroleptics  have  an  adverse  effect  on  the 
response  to  TSD.  The  first  possibility  is  less  prob- 
able,  in  view  of  the  evidence  that  depressives  with 
psychotic  features  tend  to  react  more  favorably  to 
TSD  than  non-psychotic  depressives  (Elsenga  and 
van  den  Hoofdakker,  1987).  We  are  unaware  of 
any  studies  corroborating  or  contradicting  the  sec- 
ond  possibility.  If  other  investigations  would  con- 
firm  an  adverse  effect  of  neuroleptics  on  the  anti- 
depressant  response  to  sleep  deprivation,  this 
might  shed  an  interesting  light  on  the  mechanism 
by  which  it  takes  place. 
The  frequent  use  of  neuroleptics  in  the  present 
sample  of  patients  might  also  explain  the  com- 
paratively  small  number  of  responders  -  35%. 
This  contrasts  with  the  average  response  rate  of 
58%  estimated  on  the  basis  of  some  30  studies 
(Gillin.  1983).  Other  possible  explanations  for  the 
small  number  of  responders,  however,  include  ran- 
dom  fluctuation,  the  fact  that  responses  in  the 
present  study  were  defined  on  the  basis  of  self-rat- 
ings  (observers  often  note  an  improvement  when 
the  patient  himself  does  not),  and  the  trend, 
according  to  our  impression,  that  depressed  pa- 
tients  referred  to  University  Hospitals  (at  least 
ours)  over  the  years  are  increasingly  therapy-re- 
sistant. 
Despite  the  fact  that  the  immediate  antide- 
pressant  response  to  bright  light  TSD  was  not 
greater  than  that  to  dim  light  TSD,  there  was 
some  evidence  that,  in  the  subgroup  of  responders, 
the  response  was  more  protracted  after  bright  light 
TSD.  As  explained  above,  the  design  of  our  study 
was  directed  toward  the  possibility  that  the  ex- 
posure  to  bright  light,  perhaps  in  combination 
with  the  medication  administered,  might  counter- 
act  the  usual  relapse  after  the  first  night  of  sleep 
following  TSD.  Fig.  2  suggests  this  effect  only  for 
the  second  bright  light  TSD.  To  what  extent  the 
antidepressant  medication  might  have  been  a con- 116 
tributing  factor  is  also  difficult  to  assess  here. 
Antidepressant  medication  per  se  has  been  found 
to  prolong  the  response  to  sleep  deprivation  (Loo- 
sen  et  al.,  1976;  Philip,  1978;  Baxter  et  al.,  1986), 
and  a relapse-suppressing  effect  due  to  an  interac- 
tion  with  exposure  to  bright  light  is  possible.  We 
have  tried  to  derive  an  indication  in  this  direction 
from  the  individual  data  of  the  patients,  but  these 
efforts  were  unrewarding.  Whatever  the  cause, 
however,  the  general  trend  in  the  self-ratings  sug- 
gests  that  a  continuation  of  the  bright  light  TSD 
regimen  might  have  shown  a further  improvement. 
A  new  study  will  be  required  to  investigate  this 
possibility.  It  should  be  noted,  however,  that  over- 
all  there  is  not  much  evidence  to  suggest  that  the 
procedures  applied  in  the  present  study  would 
lead  to  a substantial  long-term  improvement,  either 
for  the  non-responders  to  TSD  or  for  the  re- 
sponders.  From  Table  1  it  can  be  gathered  that 
from  Monday  1  to  Monday  3  the  total  group 
improved  by  4.0  points  on  the  Beck  Depression 
Inventory,  which  does  not  seem  particularly  im- 
pressive  considering  that  time,  medication,  and 
possibly  also  a  placebo  effect  may  all  have  con- 
tributed  to  this  change.  The  improvement  after  2 
weeks  was  even  greater  in  the  group  of  non-re- 
sponders  (4.4  points)  than  in  the  group  of  re- 
sponders  (3.4  points).  Thus,  perhaps,  another  kind 
of  design  in  which  some  form  of  sleep  deprivation 
is combined  with  the  administration  of  bright  light 
may  be  considered  for  use  in  future  studies.  Par- 
tial  sleep  deprivation  late  in  the  night  (Sack  et  al., 
1988),  followed  by  exposure  to  bright  light  in  the 
early  morning,  may  be  a  promising  alternative. 
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